Moderna, Inc.
200.10USD
-2.5300 (-1.25%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MRNA.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$1.28▼ | -$1.22 | 3 | 0 |
| Next quarter | -$1.86▲ | -$2.06 | 1 | 2 |
| Current year | -$8.49▲ | -$8.66 | 2 | 1 |
| Next year | -$4.88▼ | -$4.75 | 2 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$2.06 | -$1.97 | +0.09 (+4.3%) |
| 2026-03-31 | -$3.88 | -$3.4 | +0.48 (+12.4%) |
| 2025-12-31 | -$2.6 | -$2.11 | +0.49 (+18.9%) |
| 2025-09-30 | -$2.18 | -$0.51 | +1.67 (+76.6%) |
224 ratings from 30 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $40 $90 | Oct 21, 2026 |
| Goldman Sachs | Maintained | Neutral | $120 $137 | Oct 15, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $89 $95 | Oct 7, 2026 |
| Citigroup | Downgraded from Neutral | Sell | $60 $80 | Sep 30, 2026 |
| Rothschild & Co | Downgraded from Neutral | Sell | $40 $81 | Sep 3, 2026 |
| Argus Research | Upgraded from Hold | Buy | $180 | Aug 28, 2026 |
| Wolfe Research | Upgraded from Underperform | Peer Perform | — | Aug 25, 2026 |
| Barclays | Maintained | Equal-Weight | $48 $125 | Aug 24, 2026 |
| JP Morgan | Maintained | Underweight | $40 $77 | Aug 21, 2026 |
| Goldman Sachs | Maintained | Neutral | $67 $120 | Aug 20, 2026 |
| UBS | Maintained | Neutral | $50 $150 | Aug 20, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $39 $89 | Aug 20, 2026 |
| William Blair | Upgraded from Market Perform | Outperform | — | Aug 19, 2026 |
| Citigroup | Maintained | Neutral | $41 $60 | Aug 3, 2026 |
| Goldman Sachs | Maintained | Neutral | $49 $67 | Jul 21, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $33 $39 | Jul 8, 2026 |
| RBC Capital | Maintained | Sector Perform | $38 $45 | Jul 7, 2026 |
| B of A Securities | Maintained | Underperform | $34 $38 | Jul 7, 2026 |
| Piper Sandler | Maintained | Overweight | $69 $77 | Jun 26, 2026 |
| B of A Securities | Maintained | Underperform | $32 $34 | Jun 8, 2026 |
| UBS | Maintained | Neutral | $36 $45 | May 4, 2026 |
| Goldman Sachs | Maintained | Neutral | $43 $49 | May 4, 2026 |
| Evercore ISI Group | Maintained | In-Line | $35 $50 | May 4, 2026 |
| RBC Capital | Maintained | Sector Perform | $35 $38 | May 4, 2026 |
| Barclays | Maintained | Equal-Weight | $25 $48 | Apr 2, 2026 |
175 filings from 15 insiders · 31 buy / 10 sell over 6m
Officers and directors of MRNA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Hoge StephenOfficer, President | ExerciseStock Option (Right to Buy) | 76.5k | — | — | Oct 15, 2026 |
| Hoge StephenOfficer, President | Sell | 39.1k | $220.72 | $8.64M | Oct 15, 2026 |
| Hoge StephenOfficer, President | Exercise | 76.5k | $12.21 | $933k | Oct 15, 2026 |
| Hoge StephenOfficer, President | ExerciseStock Option (Right to Buy) | 76.5k | — | — | Oct 14, 2026 |
| Hoge StephenOfficer, President | Sell | 450 | $214.15 | $96k | Oct 14, 2026 |
| Hoge StephenOfficer, President | Sell | 38.8k | $213.47 | $8.28M | Oct 14, 2026 |
| Hoge StephenOfficer, President | Exercise | 76.5k | $12.21 | $933k | Oct 14, 2026 |
| Mock James MOfficer, Chief Financial Officer | ExerciseRestricted Stock Units | 1.5k | — | — | Oct 5, 2026 |
| Mock James MOfficer, Chief Financial Officer | Tax | 704 | $190.01 | $134k | Oct 5, 2026 |
| Mock James MOfficer, Chief Financial Officer | Exercise | 1.5k | — | — | Oct 5, 2026 |
| Hoge StephenOfficer, President | ExerciseStock Option (Right to Buy) | 76.5k | — | — | Sep 15, 2026 |
| Hoge StephenOfficer, President | Sell | 40.3k | $146.07 | $5.88M | Sep 15, 2026 |
| Hoge StephenOfficer, President | Exercise | 76.5k | $12.21 | $933k | Sep 15, 2026 |
| Hoge StephenOfficer, President | ExerciseStock Option (Right to Buy) | 76.5k | — | — | Sep 14, 2026 |
| Hoge StephenOfficer, President | Sell | 40.3k | $144.13 | $5.81M | Sep 14, 2026 |
| Hoge StephenOfficer, President | Exercise | 76.5k | $12.21 | $933k | Sep 14, 2026 |
| Mock James MOfficer, Chief Financial Officer | ExerciseStock Option (Right to Buy) | 19.8k | — | — | Sep 10, 2026 |
| Mock James MOfficer, Chief Financial Officer | Sell | 15.0k | $134.49 | $2.02M | Sep 10, 2026 |
| Mock James MOfficer, Chief Financial Officer | Sell | 19.8k | $134.49 | $2.67M | Sep 10, 2026 |
| Mock James MOfficer, Chief Financial Officer | Exercise | 19.8k | $30.96 | $614k | Sep 10, 2026 |
No analyst notes on MRNA yet.
Analyst Ratings
19 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 4 | 14 | 2 | 1 | Hold2.91 |
| 1 mo ago | 1 | 4 | 15 | 2 | 1 | Hold2.91 |
| 2 mo ago | 1 | 4 | 17 | 0 | 1 | Hold2.83 |
| 3 mo ago | 2 | 2 | 16 | 1 | 2 | Hold2.96 |
Members whose judged calls on MRNA have played out most reliably.
No settled calls on MRNA yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice